Antimicrobial resistance (AMR)
Microorganisms that are resistant to antimicrobial drugs (for example antibiotics and antifungal drugs) are a major threat to human and animal health. This threat will not cease, as microbes are constantly evolving and will continue to develop resistance to antimicrobial products.
Combatting antimicrobial resistance (AMR) demands a range of approaches, including strategies to reduce the selective pressure on microbes; retain the efficacy of current antimicrobial products through good practice; and develop new products, tools and technologies.
Applied microbiology is uniquely able to contribute in three areas in particular:
- Research within the ‘One Health’ agenda, integrating human, animal and environmental focused research.
- Environmental aspects of AMR, especially transmission of resistance genes and genetic elements.
- Global collaboration and coordination of surveillance and environmental monitoring.
The Society for Applied Microbiology collaborates with partner organisations, industry representatives, public sector workers and policymakers to promote the value of applied microbiology to multidisciplinary research & development approaches in this area.
A 20-year vision and five-year action plan for the UK that aims to contain, control and mitigate antimicrobial resistance has been announced.